Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases-a Japanese Nationwide Survey.

Shin KobayashiToru BeppuGoro HondaMasakazu YamamotoKeiichi TakahashiItaru EndoKiyoshi HasegawaKenjiro KotakeMichio ItabashiYojiro HashiguchiYoshihito KoteraKatsunori SakamotoTatsuro YamaguchiSatoshi MoritaKen TabuchiMasaru MiyazakiKenichi Sugihara

Published in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2019)

Adjuvant chemotherapy has a survival benefit for patients with resected CRLM. Synchronous CRLM is a favorable indication for AC, whereas in metachronous CRLM, the use of AC should be individualized according to each patient's risk factors.

Keyphrases

liver metastases
risk factors
lymph node
free survival
case report
prognostic factors